Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
496815
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/13/1153
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
FDA ORPHAN DRUG |
487415
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
FDA ORPHAN DRUG |
488615
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
FDA ORPHAN DRUG |
397113
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
DARZALEX (AUTHORIZED: MULTIPLE MYELOMA)
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
FDA ORPHAN DRUG |
769220
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
NCI_THESAURUS |
C155321
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
NCI_THESAURUS |
C129822
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
NDF-RT |
N0000192336
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
FDA ORPHAN DRUG |
536216
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
||
|
WHO-ATC |
L01XC24
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C74007
Created by
admin on Mon Mar 31 20:43:56 GMT 2025 , Edited by admin on Mon Mar 31 20:43:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL2109269
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
DARATUMUMAB
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
DB09331
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
4Z63YK6E0E
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
945721-28-8
Created by
admin on Mon Mar 31 20:43:56 GMT 2025 , Edited by admin on Mon Mar 31 20:43:56 GMT 2025
|
PRIMARY | |||
|
100000162382
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
1721947
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | RxNorm | ||
|
Daratumumab
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
AB-73
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
SUB175772
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
5063
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
m11896
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL1743007
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
4Z63YK6E0E
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | |||
|
N0000192335
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY | CD38-directed Antibody Interactions [MoA] | ||
|
9128
Created by
admin on Mon Mar 31 20:43:57 GMT 2025 , Edited by admin on Mon Mar 31 20:43:57 GMT 2025
|
PRIMARY |
ACTIVE MOIETY